Obtusaquinone: A Cysteine-Modifying Compound That Targets Keap1 for Degradation Post date May 26, 2022 ← Vascular Stiffening Mediated by Rho-Associated Coiled-Coil Containing Kinase Isoforms → Highly Efficient Activatable MRI Probe to Sense Myeloperoxidase Activity
Neurovascular Research UnitNeurovascular Research Unit